AA
ATRC icon

AlphaCentric Advisors’s AtriCure ATRC Stock Holding History

AlphaCentric Advisors’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$796K Buy
+26,035
New +$837K 0.79% 34

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AlphaCentric Advisors's ATRC Position: Q4 2024 in Review

AlphaCentric Advisors opened a new position in AtriCure (ATRC) in Q4 2024: 26,035 shares worth $796K. The stake represents 0.79% of the portfolio and ranks #34 among its holdings.

213 funds tracked by Wall St. Rank hold ATRC as of Q4 2024.

  • AlphaCentric Advisors held 26,035 shares of AtriCure worth $796K as of Q4 2024.
  • AtriCure was a new AlphaCentric Advisors position in Q4 2024.
  • AtriCure made up 0.79% of AlphaCentric Advisors's portfolio in Q4 2024, its #34 holding.
  • 213 funds tracked by Wall St. Rank held AtriCure as of Q4 2024.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.